These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 34581522)

  • 1. Why Fast COVID-19 Vaccination Needed for People with Disabilities and Autistics in Korea?
    Yoon WH
    J Korean Med Sci; 2021 Sep; 36(37):e267. PubMed ID: 34581522
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Developing a Framework for Pandemic COVID-19 Vaccine Allocation: a Modified Delphi Consensus Study in Korea.
    Choi MJ; Choi WS; Seong H; Choi JY; Kim JH; Kim YJ; Cho EY; Kim DH; Park H; Lee H; Kim NJ; Song JY; Cheong HJ; Kim SI; Peck KR
    J Korean Med Sci; 2021 Jun; 36(23):e166. PubMed ID: 34128597
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Preparing for the Coronavirus Disease (COVID-19) Vaccination: Evidence, Plans, and Implications.
    Jung J
    J Korean Med Sci; 2021 Feb; 36(7):e59. PubMed ID: 33619920
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The importance of seasonal influenza vaccination for people with disabilities during the COVID-19 pandemic.
    Peacock G; Ryerson AB; Koppaka R; Tschida J
    Disabil Health J; 2021 Apr; 14(2):101058. PubMed ID: 33384278
    [TBL] [Abstract][Full Text] [Related]  

  • 5. COVID-19 Vaccination in Korea: Past, Present, and the Way Forward.
    Nham E; Song JY; Noh JY; Cheong HJ; Kim WJ
    J Korean Med Sci; 2022 Dec; 37(47):e351. PubMed ID: 36472087
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Contact-adjusted Immunity Levels against SARS-CoV-2 in Korea and Prospects for Achieving Herd Immunity.
    Chun JY; Jeong H; Kim Y
    J Korean Med Sci; 2021 Oct; 36(38):e272. PubMed ID: 34609093
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efforts towards a COVID-19 vaccine.
    Brüssow H
    Environ Microbiol; 2020 Oct; 22(10):4071-4084. PubMed ID: 32893468
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Induction of High Levels of Specific Humoral and Cellular Responses to SARS-CoV-2 After the Administration of Covid-19 mRNA Vaccines Requires Several Days.
    Gil-Manso S; Carbonell D; López-Fernández L; Miguens I; Alonso R; Buño I; Muñoz P; Ochando J; Pion M; Correa-Rocha R
    Front Immunol; 2021; 12():726960. PubMed ID: 34671348
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sars-Cov-2 virus and vaccination; biological and statistical framework.
    Arslan F; Ankaralı H
    Expert Rev Vaccines; 2021 Sep; 20(9):1059-1063. PubMed ID: 34365880
    [TBL] [Abstract][Full Text] [Related]  

  • 10. COVID-19 vaccination hesitancy among Americans with disabilities aged 18-65: An exploratory analysis.
    Myers A; Ipsen C; Lissau A
    Disabil Health J; 2022 Jan; 15(1):101223. PubMed ID: 34663563
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Projecting the Impact of SARS-CoV-2 Variants and the Vaccination Program on the Fourth Wave of the COVID-19 Pandemic in South Korea.
    Shim E
    Int J Environ Res Public Health; 2021 Jul; 18(14):. PubMed ID: 34300029
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Convergence between global BCG vaccination and COVID-19 pandemic.
    Islam MZ; Zahan MK; Al-Bari MAA
    J Med Virol; 2021 Mar; 93(3):1496-1505. PubMed ID: 32827313
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Self-reported COVID-19 vaccination acceptance and hesitancy among autistic adults.
    Shea LL; Becker A; Lee BK; Miller KK; Cooper D; Anderson K; Salzer MS; Vanness DJ
    Vaccine; 2022 May; 40(24):3288-3293. PubMed ID: 35484038
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Why Oxford's positive COVID vaccine results are puzzling scientists.
    Callaway E
    Nature; 2020 Dec; 588(7836):16-18. PubMed ID: 33230278
    [No Abstract]   [Full Text] [Related]  

  • 15. Viral targets for vaccines against COVID-19.
    Dai L; Gao GF
    Nat Rev Immunol; 2021 Feb; 21(2):73-82. PubMed ID: 33340022
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inclusion of pregnant individuals among priority populations for coronavirus disease 2019 vaccination for all 50 states in the United States.
    Grünebaum A; McCullough LB; Litvak A; Chervenak FA
    Am J Obstet Gynecol; 2021 May; 224(5):536-539. PubMed ID: 33545113
    [No Abstract]   [Full Text] [Related]  

  • 17. A Promising Vaccination Strategy against COVID-19 on the Horizon: Heterologous Immunization.
    Mattoo SS; Myoung J
    J Microbiol Biotechnol; 2021 Dec; 31(12):1601-1614. PubMed ID: 34949742
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comprehensive characterization of the antibody responses to SARS-CoV-2 Spike protein finds additional vaccine-induced epitopes beyond those for mild infection.
    Garrett ME; Galloway JG; Wolf C; Logue JK; Franko N; Chu HY; Matsen FA; Overbaugh JM
    Elife; 2022 Jan; 11():. PubMed ID: 35072628
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of Pfizer/BioNTech and Oxford/AstraZeneca vaccines against COVID-19 morbidity and mortality in real-world settings at countrywide vaccination campaign in Saudi Arabia.
    Meo SA; Fahad Al-Jassir F; Al-Qahtani S; Albarrak R; Usmani AM; Klonoff DC
    Eur Rev Med Pharmacol Sci; 2021 Nov; 25(22):7185-7191. PubMed ID: 34859883
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Vaccination of Pregnant Women Against COVID-19.
    Abu-Raya B
    Neoreviews; 2021 Sep; 22(9):e570-e573. PubMed ID: 34470758
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.